John Pinching | PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Fri, 25 Apr 2025 13:36:12 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png John Pinching | PharmaTimes https://pharmatimes.com 32 32 232894315 All systems go! https://pharmatimes.com/web_exclusives/all-systems-go/ Fri, 25 Apr 2025 11:47:51 +0000 https://pharmatimes.com/?p=103158 Where to purchase reliable pharmacy automation systems

]]> 103158 Mosaic therapeutics expands pipeline with Astex deal https://pharmatimes.com/uncategorized/mosaic-therapeutics-expands-pipeline-with-astex-deal/ Fri, 25 Apr 2025 11:34:09 +0000 https://pharmatimes.com/?p=103156 Cambridge firm in-licenses two oncology programmes

]]> 103156 Acoramidis approved for heart condition treatment https://pharmatimes.com/news/acoramidis-approved-for-heart-condition-treatment/ Fri, 25 Apr 2025 11:26:43 +0000 https://pharmatimes.com/?p=103154 MHRA authorises drug for adults with rare heart muscle damage

]]> 103154 Leqembi approved as first treatment to slow early Alzheimer’s progression https://pharmatimes.com/news/leqembi-approved-as-first-treatment-to-slow-early-alzheimers-progression/ Wed, 16 Apr 2025 09:07:26 +0000 https://pharmatimes.com/?p=103126 European Commission grants authorisation for Eisai and Biogen therapy

]]> 103126 Pepaxti shows effectiveness in heavily pretreated multiple myeloma patients https://pharmatimes.com/news/pepaxti-shows-effectiveness-in-heavily-pretreated-multiple-myeloma-patients/ Wed, 16 Apr 2025 08:54:31 +0000 https://pharmatimes.com/?p=103124 New real-world data reinforce treatment benefit

]]> 103124 New data reinforce daratumumab as standard of care for multiple myeloma https://pharmatimes.com/news/new-data-reinforce-daratumumab-as-standard-of-care-for-multiple-myeloma/ Tue, 15 Apr 2025 07:46:09 +0000 https://pharmatimes.com/?p=103122 Long-term survival projections suggest improved outcomes for patients

]]> 103122 Global data highlights effectiveness of romosozumab https://pharmatimes.com/news/global-data-highlights-effectiveness-of-romosozumab/ Tue, 15 Apr 2025 07:34:34 +0000 https://pharmatimes.com/?p=103120 Studies show improved bone mineral density and healthcare cost reductions

]]> 103120 UK clinical trials regulations signed into law https://pharmatimes.com/news/uk-clinical-trials-regulations-signed-into-law/ Mon, 14 Apr 2025 09:04:53 +0000 https://pharmatimes.com/?p=103118 Major update aims to accelerate research and strengthen patient safety

]]> 103118 New test prototype for monitoring MGUS patients funded https://pharmatimes.com/news/new-test-prototype-for-monitoring-mgus-patients-funded/ Mon, 14 Apr 2025 08:51:37 +0000 https://pharmatimes.com/?p=103116 Birmingham researchers to make MGUS monitoring more efficient

]]> 103116 Endlyz Therapeutics emerges with pipeline for Parkinson’s disease https://pharmatimes.com/news/endlyz-therapeutics-emerges-with-pipeline-for-parkinsons-disease/ Mon, 07 Apr 2025 10:08:11 +0000 https://pharmatimes.com/?p=103098 Research targets lysosomal function restoration for neurodegeneration

]]> 103098